119 related articles for article (PubMed ID: 28964810)
1. The tobacco carcinogen NNK disturbs mitotic chromosome alignment by interrupting p53 targeting to the centrosome.
Park JE; Jang YL; Jang CY
Toxicol Lett; 2017 Nov; 281():110-118. PubMed ID: 28964810
[TBL] [Abstract][Full Text] [Related]
2. Arsenite promotes centrosome abnormalities under a p53 compromised status induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Liao WT; Yu HS; Lin P; Chang LW
Toxicol Appl Pharmacol; 2010 Feb; 243(1):55-62. PubMed ID: 19931552
[TBL] [Abstract][Full Text] [Related]
3. Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.
Ge GZ; Xu TR; Chen C
Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):477-87. PubMed ID: 26040315
[TBL] [Abstract][Full Text] [Related]
4. Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Herzog CR; Desai D; Amin S
Biochem Biophys Res Commun; 2006 Mar; 341(3):856-63. PubMed ID: 16455056
[TBL] [Abstract][Full Text] [Related]
5. Tobacco nitrosamine NNK increases ALDH-positive cells via ROS-Wnt signaling pathway in A549 human lung cancer cells.
Hirata N; Yamada S; Sekino Y; Kanda Y
J Toxicol Sci; 2017; 42(2):193-204. PubMed ID: 28321046
[TBL] [Abstract][Full Text] [Related]
6. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [corrected] induces CRM1-dependent p53 nuclear accumulation in human bronchial epithelial cells.
Chen L; Shao C; Cobos E; Wang JS; Gao W
Toxicol Sci; 2010 Jul; 116(1):206-15. PubMed ID: 20421341
[TBL] [Abstract][Full Text] [Related]
7. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis.
Akopyan G; Bonavida B
Int J Oncol; 2006 Oct; 29(4):745-52. PubMed ID: 16964372
[TBL] [Abstract][Full Text] [Related]
8. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.
Rivenson A; Hoffmann D; Prokopczyk B; Amin S; Hecht SS
Cancer Res; 1988 Dec; 48(23):6912-7. PubMed ID: 3180100
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.
Anderson LM; Hecht SS; Dixon DE; Dove LF; Kovatch RM; Amin S; Hoffmann D; Rice JM
Cancer Res; 1989 Jul; 49(14):3770-5. PubMed ID: 2736518
[TBL] [Abstract][Full Text] [Related]
10. Combined antioxidant (beta-carotene, alpha-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model.
Kim Y; Chongviriyaphan N; Liu C; Russell RM; Wang XD
Carcinogenesis; 2006 Jul; 27(7):1410-9. PubMed ID: 16401635
[TBL] [Abstract][Full Text] [Related]
11. Pre- and post-initiation chemoprevention activity of 2-alkyl/aryl selenazolidine-4(R)-carboxylic acids against tobacco-derived nitrosamine (NNK)-induced lung tumors in the A/J mouse.
Franklin MR; Moos PJ; El-Sayed WM; Aboul-Fadl T; Roberts JC
Chem Biol Interact; 2007 Jul; 168(3):211-20. PubMed ID: 17543294
[TBL] [Abstract][Full Text] [Related]
12. Induction of Lung Tumors and Mutational Analysis in FVB/N Mice Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone.
Rothenberger NJ; Stabile LP
Methods Mol Biol; 2020; 2102():149-160. PubMed ID: 31989553
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenesis of smoking carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is related to its ability to stimulate thromboxane synthase and enhance stemness of non-small cell lung cancer stem cells.
Liu Y; Yang S; Li MY; Huang R; Ng CS; Wan IY; Long X; Wu J; Wu B; Du J; Mok TS; Underwood MJ; Chen GG
Cancer Lett; 2016 Jan; 370(2):198-206. PubMed ID: 26518146
[TBL] [Abstract][Full Text] [Related]
15. The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and Head and Neck Squamous Cancer Cells.
Doukas SG; Vageli DP; Lazopoulos G; Spandidos DA; Sasaki CT; Tsatsakis A
Cells; 2020 Apr; 9(4):. PubMed ID: 32326378
[TBL] [Abstract][Full Text] [Related]
16. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors.
Oreffo VI; Lin HW; Padmanabhan R; Witschi H
Carcinogenesis; 1993 Mar; 14(3):451-5. PubMed ID: 8453721
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Kalscheuer S; Zhang X; Zeng Y; Upadhyaya P
Carcinogenesis; 2008 Dec; 29(12):2394-9. PubMed ID: 18780894
[TBL] [Abstract][Full Text] [Related]
18. Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors.
Granville CA; Warfel N; Tsurutani J; Hollander MC; Robertson M; Fox SD; Veenstra TD; Issaq HJ; Linnoila RI; Dennis PA
Clin Cancer Res; 2007 Apr; 13(7):2281-9. PubMed ID: 17404113
[TBL] [Abstract][Full Text] [Related]
19. The tobacco carcinogen nitrosamine induces a differential gene expression response in tumour susceptible A/J and resistant C3H mouse lungs.
Gordon W; Galitovskiy V; Edwards R; Andersen B; Grando SA
Eur J Cancer; 2013 Feb; 49(3):725-33. PubMed ID: 23010150
[TBL] [Abstract][Full Text] [Related]
20. NNK, a tobacco-specific carcinogen, inhibits the expression of lysyl oxidase, a tumor suppressor.
Cheng G; Li J; Zheng M; Zhao Y; Zhou J; Li W
Int J Environ Res Public Health; 2014 Dec; 12(1):64-82. PubMed ID: 25546273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
